Did someone mention glass houses?

The FDA has cited Novo Nordisk for “quality lapses” at one of the company’s two Ozempic manufacturing plants. This facility, in Denmark, is the second Novo plant dinged for potential contamination issues — the other is in North Carolina. The Denmark issue is bad enough that the company doesn’t expect it to be resolved this year.

A federal judge has ruled against Novo Nordisk in a case the company made against a compounding...

Novo Nordisk is sending out cease-and-desist letters to compounders since the FDA marked the...

In a ruling published this week, the U.S. District Court for the Middle District of Florida, Tampa...

Did someone mention glass houses?

Related posts

Another loss for Novo

Novo’s cease-and-desist letters — what to know

Court publishes dismissal in Novo case against Brooksville